机译:适当的可植入型心肌癌患者在心脏再同步治疗 - 除颤器(CRT-D)患者接受设备替代的患者:从CRT-D降级到CRT-起搏器的时间? 解码CRT-D分析中现实世界临床实践的见解
Catholic Univ Sacred Heart Rome Dept Cardiovasc Sci Via Largo Francesco Vito 1 I-00168 Rome;
Azienda Osped Univ Policlin St Orsola Bologna Italy;
Univ Naples 2 Monaldi Hosp Naples Italy;
AS Osped S Croce &
Carle Cuneo Italy;
AO Univ S Giovanni Di Dio E Ruggi DAragona Salerno Italy;
Osped Casa Sollievo Sofferenza San Giovanni Rotondo Italy;
AO IRCCS Arcispedale S Maria Nuova Reggio Emilia Reggio Emilia Italy;
Osped S Maria Misericordia Rovigo Italy;
Azienda Osped Univ Policlin S Maria Delle Scotte Siena Italy;
Osped PA Micone Genoa Italy;
Azienda Osped Univ Ferrara Arcispedale S Anna Ferrara Italy;
PO Lodi Lodi Italy;
Osped GB Morgagni Pierantoni Forli Italy;
Boston Sci Milan Italy;
Catholic Univ Sacred Heart Rome Dept Cardiovasc Sci Via Largo Francesco Vito 1 I-00168 Rome;
Resynchronization therapy; Implantable cardioverter-defibrillator; ICD replacement; ICD indications; Device replacement; Device downgrading;
机译:适当的可植入型心肌癌患者在心脏再同步治疗 - 除颤器(CRT-D)患者接受设备替代的患者:从CRT-D降级到CRT-起搏器的时间? 解码CRT-D分析中现实世界临床实践的见解
机译:CRT-D植入患者的临床特征,死亡率,心脏住院和室性心律失常:ACTION-HF研究的结果
机译:当代ICD / CRT-D患者正在接受设备更换的设备寿命
机译:当前临床实践中用于心脏再同步治疗的植入式心脏复律除颤器的寿命:根据影响因素设备产生和制造商的分析
机译:初级预防患者的死亡率分析,接受心脏再同步除颤器(CRT-D)或植入心脏除颤器(ICD)的改善SCA研究的指导标准。